BC Cancer Foundation
Metastatic Breast Cancer Clinical Trial Forged by Epic Sciences, Canadian Consortium
Epic Sciences will donate its No Cell Left Behind platform to the clinical trial, which will enroll about 1,000 patients over three years.
Epic Sciences will donate its No Cell Left Behind platform to the clinical trial, which will enroll about 1,000 patients over three years.